IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 3 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $145,000 | -2.0% | 109,800 | +36.4% | 0.00% | – |
| Q1 2018 | $148,000 | +29.8% | 80,500 | +48.5% | 0.00% | – |
| Q4 2017 | $114,000 | -37.0% | 54,200 | -33.3% | 0.00% | – |
| Q3 2017 | $181,000 | +16.8% | 81,200 | -9.7% | 0.00% | – |
| Q2 2017 | $155,000 | -18.8% | 89,900 | +16.3% | 0.00% | – |
| Q1 2017 | $191,000 | +64.7% | 77,300 | 0.0% | 0.00% | – |
| Q4 2016 | $116,000 | -27.5% | 77,300 | +23.7% | 0.00% | – |
| Q3 2016 | $160,000 | +56.9% | 62,500 | -6.2% | 0.00% | – |
| Q2 2016 | $102,000 | -7.3% | 66,600 | +19.8% | 0.00% | – |
| Q1 2016 | $110,000 | -36.0% | 55,600 | 0.0% | 0.00% | – |
| Q4 2015 | $172,000 | -7.5% | 55,600 | 0.0% | 0.00% | – |
| Q3 2015 | $186,000 | -9.7% | 55,600 | 0.0% | 0.00% | – |
| Q2 2015 | $206,000 | +40.1% | 55,600 | +40.8% | 0.00% | – |
| Q1 2015 | $147,000 | +17.6% | 39,500 | +39.6% | 0.00% | – |
| Q4 2014 | $125,000 | +60.3% | 28,300 | -17.3% | 0.00% | – |
| Q3 2014 | $78,000 | -21.2% | 34,200 | 0.0% | 0.00% | – |
| Q2 2014 | $99,000 | +2375.0% | 34,200 | +3553.8% | 0.00% | – |
| Q1 2014 | $4,000 | 0.0% | 936 | 0.0% | 0.00% | – |
| Q4 2013 | $4,000 | +100.0% | 936 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | – | 936 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,030,604 | $4,285,000 | 0.70% |
| Virtus ETF Advisers LLC | 180,348 | $381,000 | 0.48% |
| Bain Capital Public Equity Management, LLC | 4,564,744 | $9,632,000 | 0.35% |
| Baker Brothers Advisors | 18,315,802 | $38,646,000 | 0.34% |
| Stanley-Laman Group, Ltd. | 483,773 | $1,021,000 | 0.22% |
| FIRST MIDWEST BANK TRUST DIVISION | 493,689 | $1,042,000 | 0.13% |
| GMT CAPITAL CORP | 3,875,546 | $8,178,000 | 0.08% |
| Vident Investment Advisory, LLC | 640,270 | $1,351,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 307,987 | $650,000 | 0.06% |
| NATIXIS | 3,442,519 | $7,263,000 | 0.06% |